Información del artículo
El Texto completo está disponible en PDF
References
[1.]
J.P. Dank, R. Colven.
Protease inhibitorassociated angiolipomatosis.
J Am Acad Dermatol, 42 (2000), pp. 129-131
[2.]
E. Bornhövd, A.K. Sakrauski, H. Brühl, R. Walli, G. Plewig, M. Röcken.
Multiple circumscribed subcutaneous lipomas associated with use of human immunodeficiency virus protease inhibitors.
Br J Dermatol, 143 (2000), pp. 1113-1114
[3.]
E. Dauden, S. Álvarez, A. García-Díez.
Eruptive angiolipomas associated with antiretroviral therapy.
AIDS, 16 (2002), pp. 805-806
[4.]
A. Carr, K. Samaras, D.J. Chisholm, D.A. Cooper.
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.
Lancet, 351 (1998), pp. 1881-1883
[5.]
R. Sciot, M. Akerman, P. Dal Cin, I. De Wever, C.D. Fletcher, N. Mandahl, et al.
Cytogenetic analysis of subcutaneous angiolipoma: further evidence supporting its difference from ordinary pure lipomas: a report of the CHAMP Study Group.
Am J Surg Pathol, 21 (1997), pp. 441-444
[6.]
K.V. Heath, K.J. Chan, J. Singer, M.V. O'Shaughessy, J.S.G. Montaner, R.S. Hogg.
Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy.
Int J Epidemiol, 31 (2002), pp. 1016-1020
[7.]
M. Galli, F. Veglia, G. Angarano, S. Satambrogio, E. Meneghini, F. Gritti, et al.
Gender differences in antiretroviral drug-related adipose tissue alterations. Women are at higher risk than men and develop particular lipodystrophy patterns.
J Acquir Immune Defic Syndr, 34 (2003), pp. 58-61
[8.]
C.M. Weldon-Linne, D.P. Rhone, D. Blatt, D. Moore, M. Monitz.
Angiolipomas in homosexual men.
N Engl J Med, 310 (1984), pp. 1193-1194
[9.]
K. Brinkman, J.A. Smeitink, J.A. Romijn, P. Reiss.
Mitochondrial toxicity induced by nucleoside-analogue reversetranscriptase inhibitors is a key factor in the pathogenesis of antiretroviraltherapy-related lipodystrophy.
Lancet, 354 (1999), pp. 1112-1115
Copyright © 2007. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
